An Open-Label Study of Quetiapine Extended-Release in a Sample of Postpartum Women with Bipolar II Depressive Episode

E-ISSN： 2211-5579|4|1|17-26

ISSN： 2211-5560

Source： Current Psychopharmacology, Vol.4, Iss.1, 2015-04, pp. : 17-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Extended-Release Dipyridamole following Administration through a Gastrostomy Tube: An Open-Label, Case-Control, Two-Centre Study

By Batista Leonardo M.

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 483-488

Adis International

Access to resources Recommend Favorite

Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg: A Randomized, Open-Label, Crossover, Single-Centre Study

By Darwish Mona

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 145-152

Adis International

Access to resources Recommend Favorite

Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder

By >

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 751-764

Adis International

Access to resources Recommend Favorite

Quetiapine Extended Release: Adjunctive Treatment in Major Depressive Disorder

By Sanford Mark

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 803-813

Adis International

Access to resources Recommend Favorite